Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance.
about
Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's diseaseLiquid chromatography-tandem mass spectrometry for analysis of intestinal permeability of loperamide in physiological bufferFunctional impact of ABCB1 variants on interactions between P-glycoprotein and methadoneP-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenacThe Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A ReviewFentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice.Opioids and efflux transporters. Part 4: influence of N-substitution on P-glycoprotein substrate activity of noroxymorphone analogues.Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk managementThe role of multidrug resistance-associated protein in the blood-brain barrier and opioid analgesia.Cyclosporine-inhibitable blood-brain barrier drug transport influences clinical morphine pharmacodynamics.Gabapentin and diclofenac reduce opioid consumption in patients undergoing tonsillectomy: a result of altered CNS drug delivery?Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.Loperamide-Related Deaths in North Carolina.Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain.Prescription opioids. III. Disposition of oxycodone in oral fluid and blood following controlled single-dose administration.Potential P-glycoprotein pharmacokinetic interaction of telaprevir with morphine or methadone.Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.Pharmacogenetics of opioid analgesics in dogs.The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse.Rat brain CYP2D activity alters in vivo central oxycodone metabolism, levels and resulting analgesia.
P2860
Q26999066-F08BC9ED-8311-45F7-8D3B-BF84D78A7DA0Q28485106-82C0B928-3DEA-4EC2-9294-84F2A2F84934Q28488223-54224C58-F10C-4ED5-B312-E843D86E9499Q28539683-EAC0BC61-08AE-4562-B03A-10CECC7DA1ECQ30235088-C36D2FE1-78BF-4061-BD8C-6FF7496B9D86Q35860275-675E44B7-95D0-4E29-85F8-8FE00007FF9FQ35872086-0611E152-54F8-455E-9E33-5D848850ED50Q36392325-1184A0D7-C6EA-4E97-AB76-9310264A4164Q37117550-F0E51A0F-6790-4F01-9256-C021D7215F63Q37297410-CEA75592-394D-4B3D-874D-802CEF7CDEB8Q37422109-7220CCE3-C3F2-45DC-812E-3A9B2BF10461Q38478413-63BE621A-88F3-406F-BF14-07A23052B615Q38913158-95302907-ED59-41D5-89FB-A169A866CF50Q39285381-5E23AD30-A7DF-408C-AECF-0DAE0E7FAED8Q41581475-8150964F-61D6-404A-BF69-932C4CA0E06CQ42282016-EA278169-EE47-4CD1-85FF-AD60CA200B11Q43075723-DC84B047-BAF6-46EE-8B81-81D35C591EDFQ43076078-65E6698A-00B3-440A-A6A9-308460612F90Q47149253-4A14FD9D-48A3-4461-A71E-C5A8C9A7733EQ47561935-DBC23BCA-9312-46F1-88F9-99F07CAAC01A
P2860
Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Opioid analgesics and P-glycop ...... bution to analgesic tolerance.
@ast
Opioid analgesics and P-glycop ...... bution to analgesic tolerance.
@en
type
label
Opioid analgesics and P-glycop ...... bution to analgesic tolerance.
@ast
Opioid analgesics and P-glycop ...... bution to analgesic tolerance.
@en
prefLabel
Opioid analgesics and P-glycop ...... bution to analgesic tolerance.
@ast
Opioid analgesics and P-glycop ...... bution to analgesic tolerance.
@en
P2860
P1476
Opioid analgesics and P-glycop ...... bution to analgesic tolerance.
@en
P2093
Andrew Coop
Susan L Mercer
P2860
P304
P356
10.2174/156802611795371288
P577
2011-01-01T00:00:00Z